Organization | University of Campinas

University of Campinas Report issue

Academic/Hospital Phase 1 Phase 2 Phase 3 Phase 4

Founded: Campinas São Paulo Brazil (1962)

Organization Overview

First Clinical Trial

2003

NCT01612130

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2022

Timeline

NOW

Now

Alternative names

Centro Medico Campinas | Clinical Oncology Department, State University of Campinas (UNICAMP) | Department of Ophthalmology, University of Campinas | Faculty of Medical Sciences, State University of Campinas | FCM-CG | Francisco Groppo | Instituto de Nefrologia de Campinas | Luis Bahamondes | Osias Francisco de Souza | Piracicaba Dental School, University of Campinas | STATE UNIVERSITY CAMPINAS | State University of Campinas | University of Campinas | University of Campinas, Brazil | University of Campinas (UNICAMP) | University of Campinas, UNICAMP

Active Ingredients

Drugs in Phase 4 Trials (40)

acetaminophen (tylenol) (1 trial)

acetylcysteine (mucomyst) (1 trial)

alveograf (1 trial)

amoxicillin (3 trials)

articaine (Septocaine) (1 trial)

atorvastatin (lipitor) (1 trial)

bacille calmette-guerin (2 trials)

bimatoprost (lumigan) (1 trial)

calcium phosphate (1 trial)

cellulose (1 trial)

dapagliflozin (farxiga) (2 trials)

desogestrel (Mercilon) (2 trials)

dextran sulfate (1 trial)

doxycycline (vibramycin) (2 trials)

enamel matrix derivative (2 trials)

enamel matrix proteins (1 trial)

epinephrine (levophed) (1 trial)

estradiol (progynon depot) (1 trial)

evolocumab (repatha) (1 trial)

glyburide (micronase) (2 trials)

hypromelloses (2 trials)

infliximab (remicade) (1 trial)

ketamine (ketalar) (1 trial)

ketorolac (acuvail) (1 trial)

latanoprost (xalatan) (1 trial)

lidocaine (xylocaine) (2 trials)

metronidazole (flagyl) (3 trials)

misoprostol (cytotec) (1 trial)

niacin (1 trial)

nitrous oxide (1 trial)

norgestrel (Ovral) (2 trials)

procaine benzylpenicillin (novocaine) (1 trial)

ranibizumab (lucentis) (1 trial)

rimabotulinumtoxinB (Myobloc) (1 trial)

simvastatin (zocor) (2 trials)

sodium chloride (2 trials)

timolol (blocadren) (1 trial)

travoprost (travatan) (1 trial)

triclosan (1 trial)

ulipristal (ella) (1 trial)

Drugs in Phase 3 Trials (15)

amitriptyline (elavil) (2 trials)

amlodipine (norvasc) (2 trials)

heparin (liquaemin) (1 trial)

liraglutide (victoza) (1 trial)

metilcelulosa (1 trial)

midazolam (versed) (1 trial)

moxifloxacin (avelox) (2 trials)

mulungu (2 trials)

passiflora incarnata (1 trial)

povidone-iodine (1 trial)

sulfamethoxazole (gantanol) (1 trial)

trimethoprim (1 trial)

urea (2 trials)

vitamin c (2 trials)

vitamin e (2 trials)

Drugs in Phase 2 Trials (18)

adeno-associated viral with human factor ix (1 trial)

autologous dendritic cells electroporated with wt1 mrna (1 trial)

berry polyphenols (1 trial)

brazilian fruit peel (1 trial)

capecitabine (xeloda) (1 trial)

ciprofloxacin (cipro) (1 trial)

diacerein (2 trials)

hyaluronic acid (1 trial)

imatinib (gleevec) (1 trial)

insulin human (humulin) (1 trial)

irinotecan (Camptosar) (1 trial)

l-epigallocatechin (1 trial)

leukocytes (1 trial)

paclitaxel (taxol) (1 trial)

pioglitazone (actos) (1 trial)

platelet rich plasma (1 trial)

sitagliptin (januvia) (4 trials)

wp1122 (1 trial)

Drugs in Phase 1 Trials (10)

calcium carbonate (1 trial)

galactooligosaccharide (1 trial)

maltodextrin (1 trial)

mepivacaine (carbocaine) (1 trial)

olive oil (1 trial)

prilocaine (citanest) (1 trial)

ropivacaine (naropin) (2 trials)

silicon dioxide (1 trial)

sodium fluoride (3 trials)

water (1 trial)

Drugs in Other Trials (15)

betamethasone (celestone) (1 trial)

cefazolin (ancef) (1 trial)

doxorubicin (Doxil) (1 trial)

gadoteric acid (Dotarem) (1 trial)

Lactobacillus acidophilus (1 trial)

orlistat (xenical) (2 trials)

polydextrose (1 trial)

propofol (diprivan) (1 trial)

sildenafil (viagra) (1 trial)

soy protein (1 trial)

tadalafil (cialis) (1 trial)

tinidazole (tindamax) (1 trial)

valeriana officinalis (1 trial)

whey protein (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)

Adenocarcinoma (Phase 2)

Aggression (Phase 4)

Aggressive Periodontitis (Phase 4)

Albuminuria (Phase 2)

Anemia, Sickle Cell (Phase 2)

Anxiety Disorders (Phase 2)

beta-Thalassemia (Phase 3)

Carcinoma, Squamous Cell (Phase 2)

Cardiomegaly (Phase 4)

Carotid Artery Diseases (Phase 4)

Cataract (Phase 4)

Chronic Periodontitis (Phase 4)

Colorectal Neoplasms (Phase 2)

Conjunctivitis (Phase 3)

Conjunctivitis, Viral (Phase 3)

Constipation (Phase 1)

Coronary Artery Disease (Phase 4)

Coronary Disease (Phase 4)

Dental Caries (Phase 1)

Diabetes Complications (Phase 2)

Diabetes Mellitus (Phase 4)

Diabetes Mellitus, Type 2 (Phase 4)

Diabetic Nephropathies (Phase 2)

Dry Eye Syndromes (Phase 4)

Dyslipidemias (Phase 4)

Eclampsia (Phase 3)

Endometriosis (Phase 4)

Endophthalmitis (Phase 3)

Esotropia (Phase 4)

Exotropia (Phase 4)

Fluoride Poisoning (Phase 1)

Fluorosis, Dental (Phase 1)

Head and Neck Neoplasms (Phase 4)

HELLP Syndrome (Phase 3)

Hemophilia A (Phase 2)

Hemophilia B (Phase 2)

Hemorrhage (Phase 4)

Hypersensitivity (Phase 4)

Hypertension (Phase 4)

Hypertrophy (Phase 4)

Hypoalphalipoproteinemias (Phase 4)

Infarction (Phase 4)

Insulin Resistance (Phase 4)

Iron Overload (Phase 3)

Kidney Diseases (Phase 2)

Kidney Failure, Chronic (Phase 3)

Leukemia (Phase 2)

Leukemia, Myelogenous, Chronic, BCR-ABL Positive (Phase 2)

Leukemia, Myeloid (Phase 2)

Leukemia, Myeloid, Acute (Phase 2)

Macular Degeneration (Phase 4)

Macular Edema (Phase 4)

Menorrhagia (Phase 4)

Multiple Myeloma (Phase 2)

Myelodysplastic Syndromes (Phase 2)

Myocardial Infarction (Phase 4)

Myocardial Ischemia (Phase 4)

Neoplasms (Phase 2)

Neoplasms, Plasma Cell (Phase 2)

Obesity (Phase 4)

Osteoarthritis (Phase 2)

Pain, Postoperative (Phase 4)

Periodontal Diseases (Phase 4)

Periodontitis (Phase 4)

Pre-Eclampsia (Phase 3)

Preleukemia (Phase 2)

Pulpitis (Phase 4)

Rectal Neoplasms (Phase 2)

Recurrence (Phase 3)

Renal Insufficiency (Phase 3)

Renal Insufficiency, Chronic (Phase 3)

Strabismus (Phase 4)

Syndrome (Phase 2)

Thalassemia (Phase 3)

Thinness (Phase 4)

Tooth, Impacted (Phase 3)

Toxoplasmosis (Phase 3)

Toxoplasmosis, Ocular (Phase 3)

Uveitis (Phase 4)

Uveitis, Anterior (Phase 4)

Vulvodynia (Phase 3)

Wounds and Injuries (Phase 2)

Overview

Highest Phase: Phase 4
# of Trials: 86
# of Trial APIs: 98